Bank Julius Baer & Co’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.01M | Sell |
12,183
-1,693
| -12% | -$140K | ﹤0.01% | 336 |
|
|
2025
Q1 | $1.27M | Buy |
13,876
+722
| +5% | +$66.2K | ﹤0.01% | 304 |
|
|
2024
Q4 | $1.31M | Buy |
13,154
+487
| +4% | +$48.4K | ﹤0.01% | 298 |
|
|
2024
Q3 | $1.48M | Sell |
12,667
-826
| -6% | -$96.7K | 0.01% | 268 |
|
|
2024
Q2 | $1.39M | Sell |
13,493
-38,908
| -74% | -$4.01M | 0.01% | 220 |
|
|
2024
Q1 | $4.97M | Sell |
52,401
-560,889
| -91% | -$53.2M | 0.02% | 199 |
|
|
2023
Q4 | $54.8M | Sell |
613,290
-14,627
| -2% | -$1.31M | 0.23% | 92 |
|
|
2023
Q3 | $45.9M | Buy |
627,917
+26,728
| +4% | +$1.95M | 0.27% | 81 |
|
|
2023
Q2 | $50M | Buy |
601,189
+6,523
| +1% | +$543K | 0.3% | 76 |
|
|
2023
Q1 | $45.3M | Sell |
594,666
-34,434
| -5% | -$2.62M | 0.29% | 83 |
|
|
2022
Q4 | $52.3M | Sell |
629,100
-11,010
| -2% | -$914K | 0.36% | 69 |
|
|
2022
Q3 | $50.8M | Sell |
640,110
-64,877
| -9% | -$5.15M | 0.39% | 65 |
|
|
2022
Q2 | $52.4M | Sell |
704,987
-62,477
| -8% | -$4.64M | 0.37% | 65 |
|
|
2022
Q1 | $69M | Buy |
767,464
+38,654
| +5% | +$3.47M | 0.41% | 55 |
|
|
2021
Q4 | $81.6M | Buy |
728,810
+165,265
| +29% | +$18.5M | 0.44% | 54 |
|
|
2021
Q3 | $70.8M | Buy |
563,545
+127,688
| +29% | +$16.1M | 0.44% | 56 |
|
|
2021
Q2 | $59M | Buy |
435,857
+74,190
| +21% | +$10M | 0.37% | 60 |
|
|
2021
Q1 | $49.1M | Buy |
361,667
+60,396
| +20% | +$8.19M | 0.37% | 63 |
|
|
2020
Q4 | $42.4M | Buy |
301,271
+54,911
| +22% | +$7.73M | 0.35% | 60 |
|
|
2020
Q3 | $27.5M | Sell |
246,360
-36,224
| -13% | -$4.04M | 0.27% | 76 |
|
|
2020
Q2 | $31.4M | Sell |
282,584
-35,610
| -11% | -$3.96M | 0.36% | 62 |
|
|
2020
Q1 | $21.2M | Buy |
+318,194
| New | +$21.2M | 0.49% | 58 |
|